Skip to main content
. Author manuscript; available in PMC: 2010 Aug 15.
Published in final edited form as: Clin Cancer Res. 2009 Aug 11;15(16):5250–5257. doi: 10.1158/1078-0432.CCR-08-2850

Table 2.

Bortezomib and vorinostat CTC-version 3 toxicities for cycles 1 and cumulative for cycles 2–8.

Toxicity Cycle 1 Cycle 2–8
No Grade No Grade
1 2 3 4 1 2 3 4
Anemia 7 2 4 1 - 16 4 7 3 2
Neutropenia 4 2 - 2 - 7 1 3 3 -
Platelets 12 3 3 3 3 17 3 1 7 6
Diarrhea 12 9 1 2 - 11 8 1 2 -
Nausea 11 9 1 1 - 12 6 6 - -
Vomiting 5 2 2 1 - 7 4 2 1 -
Constipation 1 1 - - - 3 3 - - -
Fatigue 8 4 3 1 - 11 2 4 5 -
Fever 5 2 2 1 - 4 3 1 - -
Peripheral
neuropathy
13 11 2 - - 14 5 9 1 -
Dyspnea 0 - - - - 5 1 1 3 -
Hypotension 0 - - - - 5 3 1 1 -
Atrial fib. 0 - - - - 1 - 1 - -
Prolonged QTC 10 7 2 1 - 0 - - - -
Pneumonia 0 - - - - 3 - - 3 -
Shingles 0 - - - - 2 - 2 - -
Creatinine 7 2 5 - - 8 4 3 1 -
Hyponatremia 6 5 1 - - 10 6 - 4 -
Hypokalemia 2 - - 2 - 5 3 - 2 -
Hypocalcemia 1 1 - - - 5 2 2 1 -
LDH 5 3 2 - - 4 4 - - -
AST 4 3 1 - - 5 4 - 1 -
ALT 3 3 - - - 2 - 2 - -